Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Cardiomyopathies

cabergoline has been researched along with Cardiomyopathies in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Hayashi, T; Higuchi, Y; Hirayama, A; Ichibori, Y; Iwai, S; Makino, N; Minamiguchi, H; Mitake, A; Mori, N; Shiba, M; Shibuya, Y1
Abdallah, Y; Al Nooryani, A; ElSaeidi, E; Gafar, S; Hamdan, R; Kadri, Z1
Araujo Júnior, E; Carvalho, JS; Carvalho, RC; Costa Carvalho, FH; Feitosa, FE; Melo, MA; Peixoto, AB1
Fett, JD1
Bouma, BJ; de Jong, JS; Rietveld, K; van Lochem, LT1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S1

Other Studies

7 other study(ies) available for cabergoline and Cardiomyopathies

ArticleYear
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Adult; Cabergoline; Cardiomyopathies; Cesarean Section; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2023
[Succès de traitement par Cabergoline d'une série de cas de cardiomyopathie du péripartum, incluant un cas critique nécessitant une assistance circulatoire mécanique].
    Annales de cardiologie et d'angeiologie, 2023, Volume: 72, Issue:4

    Topics: Cabergoline; Cardiomyopathies; Humans; Peripartum Period; Shock, Cardiogenic

2023
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:6

    Topics: Adolescent; Cabergoline; Cardiomyopathies; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Puerperal Disorders

2016
Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:8

    Topics: Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Humans; Peripartum Period; Pregnancy; Puerperal Disorders

2016
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Adult; Cabergoline; Cardiomyopathies; Echocardiography; Ergolines; Female; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pregnancy; Prolactin; Puerperal Disorders; Ventricular Dysfunction, Left

2009
[Gender effect on cardiomyopathy].
    Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6

    Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome

2012